Search results for: 'platforms'

This strategic analysis is a part of Frost & Sullivan’s continued coverage of the global enterprise communications platforms and endpoints market as well as the broader, overall enterprise communications marketplace. In this Excel-based deliverable, Frost & Sullivan provides extensive market sizing and market share analysis of the on-premises enter...

Generative AI implementation vendors have the expertise to tailor complex AI models and capabilities to specific industry needs, ensuring seamless integration and maximizing the value of generative AI tools. The vendors are essential for businesses that lack in-house AI capabilities or want to accelerate their AI adoption journey. They help clients...

Both predictive and prognostic biomarkers constitutes an central element in each and every targeted oncology drug discovery and development program. Breakthrough technologies allowing leveraging biomarkers for oncology are paving the way of personalized medicine and precision oncology. Indeed, oncology biomarkers provide the clinical community with...

Therapeutically more effective drugs for the treatment of chronic diseases represents a crucial need. Biosimilars and biobetters offer the possibility to lower the cost of treating a variety of chronic diseases. In particular, biosimilars are the less expensive option; however, biobetters have demonstrated to be more effective, even over longer per...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across innovations in precision medicine, targeted drug delivery, RNA editing, biomanufacturing, cell and gene therapies. The research also comprises advances in single cell analysis, hybrid microbots, AI-powered diagnostic, bioprinting and non...

The generative AI sector faces a defining challenge: how to translate the breakthrough power of foundation models into real-world value amid unprecedented disruption. An explosion of large language models (LLMs) and multimodal AI tools promises to transform everything from enterprise productivity to creative work, yet organizations grapple with tru...

In a global landscape where companies are increasingly prioritizing transparent reporting on environmental and social concerns, initiatives for corporate ESG reporting and control are flourishing, spurred by growing awareness and concern for sustainability goals. ESG investing, propelled by its perceived ability to provide financial returns and ali...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

Clinical decision support systems (CDSS) provide actionable information for improving the decision making abilities of the health professionals. However, the traditional CDSS platforms have drawbacks such as alert fatigue, diagnostic errors, workflow disruptions that can have detrimental effect on patients health outcomes as well as healthcare prov...